The Journal of the National Comprehensive Cancer Network (JNCCN), identified by ISSN 1540-1405, is a highly respected monthly publication based in the United States and issued by the National Comprehensive Cancer Network (NCCN). As a non-open access journal indexed in the Science Citation Index (SCI), it holds a prominent position in the medical field, ranking in the first quartile of the Chinese Academy of Sciences journal classification and maintaining a strong 2022 impact factor of 12.693. The journal serves as a critical resource for the global oncology community by disseminating authoritative clinical practice guidelines, original research, reviews, and commentary that focus on the diagnosis, treatment, and prevention of cancer. With a strong emphasis on multidisciplinary integrated care and evidence-based medicine, JNCCN provides clinicians with practical, up-to-date recommendations designed to directly inform patient management. While its close affiliation with the NCCN ensures high academic influence and utility, readers are advised to consider the journal’s primary focus on U.S. clinical practices when applying its findings, potentially necessitating cross-referencing with local guidelines to ensure optimal international applicability.
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com